Trial intelligence / Profile preview

Voice quality improvement with ilaprazole in laryngopharyngeal reflux disease

KCT0004179Phase 4Not yet recruiting

Sponsor
Il-Yang Pharmaceutical
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ilaprazole in laryngopharyngeal reflux (LPR), sponsored by Il-Yang Pharmaceutical. Planned start Sep 2019; status: not yet recruiting.

02

Drugs

ilaprazole
03

Conditions

laryngopharyngeal reflux (LPR)

Beyond the preview

Go deeper on KCT0004179.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0004179.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call